Overview
Foods

Meiji Holdings Co.,Ltd.

Meiji Holdings is a pure holding company overseeing two core business segments: Food and Pharmaceuticals. The Food segment, operated primarily through Meiji Co., Ltd., produces and sells dairy products (yogurt, milk, cheese, butter), confectionery (chocolate, gummy candy), ice cream, infant formula, sports nutrition, and functional foods across Japan and international markets including China, Southeast Asia, and the Americas. The Pharmaceutical segment, operated through Meiji Seika Pharma Co., Ltd. and KM Biologics Co., Ltd., develops and markets prescription drugs, vaccines, and veterinary medicines, with a growing global generics presence through subsidiaries such as Medreich Limited and Adcock Ingram Limited.

Market Cap
¥1,195B
US$7.62B
EV
¥1,224B
US$7.80B
Stock¥4,408▲+0.34%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
8.0
x
LTM EV/EBIT
12.0
x
LTM PER
29.7
x
LTM PBR
1.5
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▲+25.7%pt
1001
Oct 24, 25 – Oct 23, 26StockTOPIX
1Aug 7, 26Q1 earnings: operating profit ¥22.7bn +27.7% YoY, beat estimates by ¥3.5bn
MC → EV Bridge
1,195BUS$7.62BMarket Cap143BUS$909M+ Debt86.3BUS$551M− Cash72.9BUS$465M− Inv. Sec.45.2BUS$288M+ NCI1,224BUS$7.80BEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
1,013US$6.46B'22/31,062US$6.77B'23/31,105US$7.05B'24/31,154US$7.36B'25/31,174US$7.49B'26/3
EBITDA 5Y (¥B)
143US$912M'22/3129US$823M'23/3140US$891M'24/3140US$891M'25/3148US$946M'26/3
Net Income 5Y (¥B)
87.5US$558M'22/369.4US$443M'23/350.7US$323M'24/350.8US$324M'25/335.1US$224M'26/3
Capital Structure
84%
EquityD/E 0.18xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
192US$1.22B81.3US$518M'22/3176US$1.12B64.4US$411M'23/3195US$1.24B49.9US$318M'24/3157US$998M52.1US$332M'25/3145US$922M117US$746M'26/3
Shareholders
Top 10 hold 35.8%
1
The Master Trust Bank of Japan, Ltd. (Trust Account)
16.20%
2
Custody Bank of Japan, Ltd. (Trust Account)
6.31%
3
Nippon Life Insurance Company (Standing Proxy: The Master Trust Bank of Japan, Ltd.)
2.47%
4
Meiji Holdings Co.,Ltd. Employee Stock Ownership Association
2.30%
5
Meiji Holdings Co.,Ltd. Business Partners' Stock Ownership Association
1.97%
6
STATE STREET BANK AND TRUST COMPANY 505001 (Standing Proxy: Mizuho Bank, Ltd.)
1.47%
7
STATE STREET BANK AND TRUST COMPANY 505103 (Standing Proxy: Mizuho Bank, Ltd.)
1.42%
8
JP MORGAN CHASE BANK 385781 (Standing Proxy: Mizuho Bank, Ltd.)
1.35%
9
JPMorgan Securities Japan Co., Ltd.
1.22%
10
JAPAN ACTIVATION CAPITAL I L.P. (Standing Proxy: MUFG Bank, Ltd.)
1.09%
Management
13 officers
Katsuya MATSUDA
Representative Director, President, CEO
Born Aug 1957 Apr 1980 Joined Meiji Dairies Corporation Jun 2012 Executive Officer, Meiji Co., Ltd. Jun 2015 Managing Executive Officer, Meiji Co., Ltd. Jun 2017 Director, Meiji Co., Ltd. (current) Jun 2017 Senior Managing Executive Officer, Meiji Co., Ltd. Jun 2018 Representative Director, Meiji Co., Ltd. Jun 2018 President, Meiji Co., Ltd. Jun 2018 Director of the Company (current) Jun 2020 Executive Officer of the Company (current) Jun 2020 COO (Food Segment) of the Company Jun 2025 Director, Meiji Seika Pharma Co., Ltd. (current) Jun 2025 Representative Director of the Company (current) Jun 2025 President of the Company (current) Jun 2025 CEO of the Company (current) Jun 2025 In charge of Corporate Planning Department (current) Jun 2025 In charge of Group Human Resources Strategy Department Jun 2025 In charge of Intellectual Property Strategy Department (current) Jun 2025 In charge of Wellness Science Lab (current) Oct 2025 In charge of Group Human Capital Strategy Department (current)
1957-08-25
Toshiaki NAGASATO
Director, Executive Officer, COO (Pharmaceuticals Segment)
Born Oct 1957 Apr 1983 Joined Meiji Seika Kaisha, Ltd. Jun 2014 Executive Officer, Meiji Seika Pharma Co., Ltd. Jun 2017 Director, Meiji Seika Pharma Co., Ltd. (current) Jun 2025 Representative Director, Meiji Seika Pharma Co., Ltd. (current) Jun 2025 President, Meiji Seika Pharma Co., Ltd. (current) Jun 2025 Director of the Company (current) Jun 2025 Executive Officer of the Company (current) Jun 2025 COO (Pharmaceuticals Segment) of the Company (current)
1957-10-01
Bunjiro YAO
Director, Executive Officer, COO (Food Segment)
Born May 1961 Apr 1984 Joined Meiji Dairies Corporation Jun 2015 Executive Officer, Meiji Co., Ltd. Jun 2017 Managing Executive Officer, Meiji Co., Ltd. Jun 2020 Director, Meiji Co., Ltd. (current) Jun 2021 Senior Managing Executive Officer, Meiji Co., Ltd. Jun 2023 Executive Vice President, Meiji Co., Ltd. Jun 2025 Representative Director, Meiji Co., Ltd. (current) Jun 2025 President, Meiji Co., Ltd. (current) Jun 2025 Director of the Company (current) Jun 2025 Executive Officer of the Company (current) Jun 2025 COO (Food Segment) of the Company (current)
1961-05-28
Jun FURUTA
Director, Vice President
Born Aug 1957 Apr 1981 Joined Meiji Seika Kaisha, Ltd. Jun 2013 Executive Officer, Meiji Co., Ltd. Jun 2014 Director of the Company (current) Jun 2014 Executive Officer of the Company Jun 2014 General Manager, IR and Public Relations Department of the Company Jun 2018 Managing Executive Officer of the Company Oct 2019 In charge of Sustainability Promotion Department of the Company Apr 2020 In charge of IR and Public Relations Department of the Company Jun 2020 Senior Managing Executive Officer of the Company Jun 2020 CSO of the Company Jun 2020 Director, Meiji Co., Ltd. (current) Apr 2022 In charge of Corporate Communications Department of the Company Apr 2024 In charge of IR Department of the Company Jun 2024 CDO of the Company Jun 2024 In charge of Risk Management Department of the Company Jun 2024 In charge of Group DX Strategy Department of the Company Jun 2025 Vice President of the Company (current) Oct 2025 In charge of Group DX Promotion Department of the Company Apr 2026 Assistant to the President of the Company (current)
1957-08-17
Jun HISHINUMA
Director, Senior Managing Executive Officer, CFO; in charge of Corporate Management, IR, IFRS Promotion and Corporate Communications Departments
Born Nov 1965 Apr 1988 Joined Meiji Dairies Corporation Jun 2022 Executive Officer, Meiji Co., Ltd. Jun 2023 Director, Meiji Co., Ltd. Jun 2023 Managing Executive Officer, Meiji Co., Ltd. Jun 2024 Director, Meiji Seika Pharma Co., Ltd. (current) Jun 2024 Director of the Company (current) Jun 2024 Managing Executive Officer of the Company (current) Jun 2024 CFO of the Company (current) Jun 2024 In charge of Corporate Management Department (current) Jun 2024 In charge of IR Department (current) Jun 2024 In charge of IFRS Promotion Department (current) Jun 2025 Senior Managing Executive Officer of the Company (current) Apr 2026 In charge of Corporate Communications Department (current)
1965-11-05
Mariko MATSUMURA
Director
Apr 1988 Registered as attorney (Daiichi Tokyo Bar Association) Apr 1988 Joined Brown Moriya Hoashi Kubota Law Office Feb 1994 Joined Ryudo Sogo Law Office Jan 2006 Joined Shinwa Sogo Law Office (current) Jun 2018 Director of the Company (current) Apr 2022 President, Daiichi Tokyo Bar Association Apr 2022 Vice President, Japan Federation of Bar Associations
1959-09-24
Masaya KAWADA
Director
Apr 1975 Joined Nisshinbo Industries, Inc. (now Nisshinbo Holdings Inc.) Jun 2006 Executive Officer, Nisshinbo Industries, Inc. Jun 2007 Director, Nisshinbo Industries, Inc. Apr 2009 Representative Director and President, Nisshinbo Brake Inc. Jun 2010 Managing Executive Officer, Nisshinbo Holdings Inc. Jun 2011 Representative Director and President, Nisshinbo Chemical Inc. Jun 2012 Senior Managing Executive Officer, Nisshinbo Holdings Inc. Jun 2012 Representative Director and President, Nisshinbo Mechatronics Inc. Jun 2013 Representative Director and President, Nisshinbo Holdings Inc. Mar 2019 Representative Director and Chairman, Nisshinbo Holdings Inc. Jun 2021 Director of the Company (current) Mar 2022 Chairman of the Board, Nisshinbo Holdings Inc.
1952-04-20
Michiko KUBOYAMA
Director
Apr 1980 Joined Kao Soap Co., Ltd. (now Kao Corporation) Apr 2006 General Manager, Product Public Relations Department, Kao Corporation Apr 2011 Center Director, Product Public Relations Center, Kao Corporation May 2016 Communication Fellow, Consumer Research Department, Kao Corporation Jun 2021 Director of the Company (current)
1956-04-16
Peter D. PEDERSEN
Director
Sep 2000 Representative Director and President, e-Square Inc. Jan 2015 Representative Director, General Incorporated Association NELIS Aug 2020 Representative Director, Specified Nonprofit Corporation Nelis (current) Jun 2022 Director of the Company (current)
1967-11-29
Masanori TAMAKI
Full-time Audit & Supervisory Board Member
Born Jun 1965 Apr 1989 Joined Meiji Dairies Corporation Jun 2019 General Manager, General Affairs and Legal Department, Meiji Co., Ltd. Apr 2022 General Manager, General Affairs and Legal Department, Corporate Headquarters, Meiji Co., Ltd. Apr 2023 General Manager, Legal Risk Management Department, Risk Management Headquarters, Meiji Co., Ltd. Apr 2024 General Manager, Legal Department, Risk Management Headquarters, Meiji Co., Ltd. Jun 2024 Executive Officer, Meiji Co., Ltd. Jun 2025 Full-time Audit & Supervisory Board Member of the Company (current)
1965-06-08
Yasushi WATANABE
Full-time Audit & Supervisory Board Member
Born Nov 1966 Apr 1989 Joined Meiji Seika Kaisha, Ltd. Jun 2016 General Manager, General Affairs Department, Meiji Seika Pharma Co., Ltd. Apr 2017 General Manager, Corporate Planning Department, Meiji Seika Pharma Co., Ltd. Oct 2017 General Manager, Corporate Planning and Management Department, Meiji Seika Pharma Co., Ltd. Jul 2018 General Manager, Business Management Department, Meiji Seika Pharma Co., Ltd. Jul 2019 General Manager, International Business Management Department, Meiji Seika Pharma Co., Ltd. Apr 2022 General Manager, Legal Department, Meiji Seika Pharma Co., Ltd. Jul 2023 Deputy Head, Business Management Headquarters, Meiji Seika Pharma Co., Ltd. Jun 2025 Full-time Audit & Supervisory Board Member of the Company (current)
1966-11-22
Makoto ANDO
Audit & Supervisory Board Member
Oct 1984 Joined Sanwa Audit Corporation Tokyo Marunouchi Office (now Deloitte Touche Tohmatsu LLC) Dec 1988 Joined KPMG Peat Marwick New York Office Apr 1991 Joined Sakurai Accounting Office Apr 1994 Joined Metropolitan Police Department Apr 2002 Joined Ando Tax & Accounting Office (now Hibiki Tax Corporation) (current) Apr 2002 Joined Ando Certified Public Accountants Joint Office (current) Jun 2017 Audit & Supervisory Board Member of the Company (current)
1959-10-08
Masakazu KOMATSU
Audit & Supervisory Board Member
Oct 2002 Registered as attorney Oct 2002 Joined Mori Sogo Law Office (now Mori Hamada & Matsumoto) Apr 2007 Opened Suenoshi Sogo Law Office (now Shiomizaka Sogo Law Office) Apr 2014 Opened Komatsu Sogo Law Office (now Kotohira Sogo Law Office LPC) (current) Jun 2023 Substitute Audit & Supervisory Board Member of the Company Jun 2025 Audit & Supervisory Board Member of the Company (current)
1977-04-06
Large Shareholding Reports
Sumitomo Mitsui Trust Asset Management Co., Ltd.
2025-12-19
2.83%
BlackRock Japan Co., Ltd.
2025-12-03
1.66%→1.75%
Nomura Asset Management Co., Ltd.
2025-08-21
4.53%
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-08-05
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-24
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-06-01
中期経営計画
TDnet
2026-02-12
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-12-19
Large Shareholding Report
EDINET
2025-12-03
Large Shareholding Report
EDINET
2025-11-13
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2025-08-21
Large Shareholding Report
TDnet
2025-08-06
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-26
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-10
Q3 Earnings Flash
FY ending Mar 2025
TDnetAmended
2024-11-11
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-11
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-09
Q1 Earnings Flash
FY ending Mar 2025
EDINETAmended
2024-07-04
Amended Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-06-27
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-05-10
中期経営計画
EDINET
2024-04-01
中期経営計画
FY ending Mar 2026
EDINET
2024-02-09
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-10
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-08
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-29
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-10
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINETAmended
2022-12-22
Amended Annual Securities Report
EDINETAmended
2022-12-22
Amended Annual Securities Report
EDINETAmended
2022-12-22
Amended Annual Securities Report
EDINETAmended
2022-12-22
Amended Annual Securities Report
EDINET
2022-11-09
Quarterly Securities Report
EDINET
2022-08-10
Quarterly Securities Report
EDINET
2022-06-29
Annual Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →